ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease
(group practice)

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,236Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 201

$947K Total Retail Price of All Prescriptions

Rank: 10 out of 201

787 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 787 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

0% of this provider’s 10,513 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
METOPROLOL SUCCINATE 1,140 941 1 6
CARVEDILOL 741 508 2 1
SIMVASTATIN 710 601 3 5
LISINOPRIL 662 503 4 2
AMLODIPINE BESYLATE 640 487 5 3
CLOPIDOGREL 615 488 6 7
DIGOXIN 513 441 7 14
PLAVIX 418 339 8 13
FUROSEMIDE 405 314 9 4
ISOSORBIDE MONONITRATE ER 348 234 10 12
METOPROLOL TARTRATE 338 295 11 8
AMIODARONE HCL 326 296 12 20
WARFARIN SODIUM 299 253 13 11
ATORVASTATIN CALCIUM 296 220 14 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 278 228 15 28
RAMIPRIL 272 233 16 22
CRESTOR 255 218 17 17
SOTALOL 244 209 18 36
PRADAXA 242 218 19 23
HYDROCHLOROTHIAZIDE 240 203 20 19
BYSTOLIC 231 182 21 33
CAPTOPRIL 197 149 22 113
LOSARTAN POTASSIUM 191 138 23 15
POTASSIUM CHLORIDE 175 150 24 16
RANEXA 175 142 24 26
EFFIENT 173 91 26 35
NITROSTAT 167 126 27 25
TORSEMIDE 155 114 28 46
LOSARTAN-HYDROCHLOROTHIAZIDE 116 104 29 34
PRAVASTATIN SODIUM 110 66 30 10
OMEPRAZOLE 107 88 31 24
ATENOLOL 104 85 32 18
KLOR-CON M20 83 57 33 31
SPIRONOLACTONE 82 54 34 21
LIPITOR 80 55 35 55
NEXIUM 78 36 36 47
CLONIDINE HCL 70 55 37 38
ISOSORBIDE DINITRATE 65 54 38 63
GEMFIBROZIL 60 40 39 91
HYDRALAZINE HCL 59 59 40 27
MULTAQ 54 54 41 56
TRACLEER 54 44 41 90
FLECAINIDE ACETATE 53 53 43 49
METOLAZONE 50 45 44 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.